Inside Life Sciences

Inside Life Sciences

Issue 4
Brexit Update

Brexit Update

As the Brexit negotiations continue, the life sciences industry remains vocal.

Read more
Access to information held by health regulators – transparency versus confidentiality

Access to information held by health regulators – transparency versus confidentiality

On 5th February, the EU General Court gave its ruling on three separate cases (PTC Therapeutics v EMA, Pari Pharma v EMA and MSD Animal Health Innovation v EMA)

Read more
Software

GDPR: Busting the myths

Readers will be well aware that the General Data Protection Regulation (GDPR) comes into effect in UK (and EU) law from 25 May 2018. Many will have been making arrangements to be ready for that date.

Read more
White Paper on the use of social media by medical professionals

White Paper on the use of social media by medical professionals

In light of the increasing use of social media messaging services by medical professionals for work-related purposes, NHS Trusts have openly stated that the technology and security standards adopted by some services are inappropriate and insufficient with regards to the standards of care required of ICT businesses operating within the health care sector. Mobile messaging services that market to medical professionals must adhere to the additional security and privacy standards required of this sensitive role.

Read more
Court of Appeal refers questions to CJEU on SPC Regulation in relation to Markush claim

Court of Appeal refers questions to CJEU on SPC Regulation in relation to Markush claim

The Court of Appeal has referred questions to the CJEU in Sandoz v Searle on the meaning of Article 3(a) of the SPC Regulation which requires that a 'product is protected by a basic patent in force'.

Read more
CJEU rules on Roche/Novartis agreement restricting off label use of Avastin

CJEU rules on Roche/Novartis agreement restricting off label use of Avastin

On 23 January 2018, the European Court of Justice (CJEU) handed down its judgment in Case C-179/16 relating to an on-going saga concerning Hoffman-La Roche Ltd (Roche) and Novartis AG (Novartis) and their attempts to restrict the off-label of Avastin.

Read more

Previous Issues

An
How can we help you?

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

I'm a client

Please enter your first name
Please enter your last name
Please enter your enquiry
Please enter a value

I'm looking for advice

Please enter your first name
Please enter your last name
Please enter your enquiry
Please select a department
Please select a contact method

Something else

Please enter your first name
Please enter your last name
Please enter your enquiry
Please select your contact method of choice